← Back to Search

Contingency Management for Substance Use Disorder

N/A

Recruiting

Research Sponsored by Wayne State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time until leaving the recovery home from study baseline up to one year

Awards & highlights

No Placebo-Only Group

Summary

This trial will study how rewards can help people with substance use disorders stay in recovery houses and engage in activities that support their recovery. House staff are trained to provide rewards.

Who is the study for?

This trial is for adults over 18 living in rural recovery houses due to substance use disorders. They must be able to make informed decisions about their participation. People with uncontrolled mania, psychosis, or suicidal thoughts, or those likely to leave the house within two months are not eligible.

What is being tested?

The study tests contingency management as a treatment in recovery houses. Participants earn rewards for activities that support their recovery. The effectiveness of this approach will be compared with usual care by looking at engagement and retention up to six months after treatment ends.

What are the potential side effects?

Since contingency management involves behavioral incentives rather than medication, traditional side effects are not expected. However, participants may experience psychological impacts from the reward-based system which will be monitored.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time until leaving the recovery home from study baseline up to one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time until leaving the recovery home from study baseline up to one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and time until leaving the recovery home from study baseline up to one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Engagement in recovery-oriented activities

Treatment retention

Secondary study objectives

Patient Health Questionnaire - 9

Quality of Life Assessment

Self-Reported Health

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Contingency managementExperimental Treatment2 Interventions

In addition to receiving usual care at the recovery house, participants assigned to this arm will receive contingency management by trained recovery house staff in addition to their usual care. Contingency management sessions will be led by a trained recovery house staff member who is also a research participant in the study. Contingency management will occur once weekly for sessions of approximately 10-15 minute duration for up to 12 weeks. Participants will plan three recovery-oriented activities with the staff member each week, and upon verification of completion of the tasks, the resident participant can earn prize draws of varying monetary amounts.

Group II: Usual CareActive Control1 Intervention

Participants in this arm will receive usual care that they would normally receive at the recovery houses. Recovery houses are safe, healthy, family-like substance-free living environments that support individuals in recovery from addiction. Although recovery residences vary considerably, this form of housing benefits individuals in recovery by reinforcing a substance-free lifestyle and providing direct connections to other peers in recovery, mutual support groups and recovery support services.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Contingency management

2006

Completed Phase 4

~1020

Usual Care

1990

Completed Phase 4

~7700